Wednesday, January 28, 2015 6:09:02 PM
--------
I actually forward your e mail to our securities lawyer and our transfer agent.
We shall see what experts can tell us.
Kind Regards
Dr. Agnes P. Olszewski Ph.D. MBA
President & CEO
Herborium Group, Inc.
Phone: 201.849.4431
Direct Line/Cell: 201.647.3757
Fax: 1.866.880.4817
Email: DrAgnes@Herborium.com
THIS MESSAGE IS INTENDED ONLY FOR THE INDIVIDUAL OR ENTITY TO WHOM OR WHICH IT IS ADDRESSED AND MAY CONTAIN INFORMATION WHICH IS CONFIDENTIAL AND PRIVILEGED. PLEASE DO NOT COPY OR DISSEMINATE THIS MESSAGE UNLESS YOU ARE THE ADDRESSEE (OR THE PERSON RESPONSIBLE FOR DELIVERING THIS MESSAGE TO THE ADDRESSEE.) IF THIS COMMUNICATION HAS BEEN SENT TO YOU IN ERROR, PLEASE CALL US AT (201)-836-2424. THANK YOU FOR YOUR COOPERATION.
`
From: Xxxxx
Sent: Wednesday, January 28, 2015 2:59 PM
To: Dr. Agnes Olszewski
Subject: what's going on?
Hello,
I am a very worried investor from the netherlands. The shareprice keeps on dropping day in, day out. What is the company going to do about it?
Hope to hear from you.
Thanks,
Karel
--------
Well.......that's at least something folks!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM